Writtle University College and ARU have merged. Writtle’s full range of college, degree, postgraduate and short courses will still be delivered on the Writtle campus. See our guide to finding Writtle information on this site.

Commercialisation Opportunities

Our researchers have developed commercialisation opportunities in a range of fields, including new medical treatments, diagnostic assays, and a game to aid physiotherapy and rehabilitation.

We're looking for commercial partners to take these opportunities to market.

Explore opportunities below.

Rapid phenotypic screening for anti-fibrotic activity

A screening service available from ARU can identify anti-fibrotic activity of novel small molecules and biologicals.

Polymerase chain reaction assays for diagnosing fungal infections

We have a suite of PCR assays available for licensing. They're robust, specific, simple and sensitive assays to identify a range of common fungal and antibiotic-resistant infections.

ReHabgame™ – a serious game for rehabilitation

Work with us on a cost-effective rehabilitation game that improves the range of motion and the kinematic ability of motor-impaired participants. Use for physiotherapy purposes at home or in community settings.

Artificial sweeteners as a cancer treatment

Our researchers have identified a potential new treatment for cancer. We're seeking a commercial partner to develop the use of sucralose as a cancer treatment.

Anti-fibrotic synergistic combination

We've identified a potential new treatment for fibrotic diseases using two generic compounds, giving the potential for a new combination therapy.

Based in ARU’s state-of-the-art Science Centre in Cambridge, ARU Biometrics apply biomedical science technologies to solve your problems. Available resources include the Applied Extracellular Vesicle Research Laboratory, Immune Checkpoint Assays, Inflammation Biology, the Platelet Function Laboratory and Workplace drug testing.

Contact us

Contact our Research and Innovation Development Office to discuss these opportunities.